endo-Gly9a-Vasopressin
| Product Name | endo-Gly9a-Vasopressin |
|---|---|
| Alternate Names | Vasopressin Impurities, Impurities of Vasopressin |
| CAT No. | CS-O-33655 |
| CAS No. | Not Available |
| Category | Impurities |
| Stock | IN-Stock |
| Mol. Wt. | 1141.28 g/mol |
| Mol. For. | C₄₈H₆₈N₁₆O₁₃S₂ |
| Hazardous | This is not a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Vasopressin |
| Purity | 95% |
| Smileys | O=C(N[C@H](C(N[C@H]1CC(N)=O)=O)CCC(N)=O)[C@@H](NC([C@@H](NC([C@@H](N)CSSC[C@H](NC1=O)C(N2CCC[C@H]2C(N[C@@H](CCC/N=C(N)/N)C(NCC(NCC(N)=O)=O)=O)=O)=O)=O)CC3=CC=C(O)C=C3)=O)CC4=CC=CC=C4.OC(C)=O |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Endo-Gly9a-Vasopressin (EGV) is a neuropeptide hormone that is involved in regulating several physiological functions in the body. It is a modified form of vasopressin, a hormone that is important for regulating water balance in the body. EGV is derived from the precursor protein preprovasopressin, which is synthesized in the hypothalamus and then transported to the posterior pituitary gland for release into circulation.
EGV has been shown to have a variety of effects in the body, including vasoconstriction, antidiuretic activity, and stimulation of the release of corticotrophin hormone. It is also involved in regulating the secretion of other hormones such as oxytocin and prolactin.
The chemical structure of EGV consists of nine amino acids, with a glycine residue at the ninth position. This modification is believed to increase the stability of the peptide and enhance its biological activity. EGV is also known to have a longer half-life than vasopressin, which means it can remain active in the body for a longer period of time.
EGV is used in research studies to investigate its potential therapeutic applications, particularly in the treatment of certain disorders such as diabetes insipidus and hypotension. Its unique chemical structure and biological activity make it an important tool for understanding the complex interactions between neuropeptides and the body's physiological processes.
Get an Instant Quote
Related Compounds
Acetylation Vasopressin | Glu4 Vasopressin | Deamidation Asn5 to Asp5 Vasopressin |